Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

J Clin Oncol 2010 May 5;28(14):2404-10. Epub 2010 Apr 5.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98006, USA.

Purpose: Women with breast cancer diagnosed early in life comprise a substantial portion of those tested for BRCA1/BRCA2 mutations; however, little information is available on the subsequent risks of contralateral breast cancer in mutation carriers. This study assessed the risk of subsequent contralateral breast cancer associated with carrying a BRCA1 or BRCA2 mutation.

Patients And Methods: In this nested case-control study, patients with contralateral breast cancer diagnosed 1 year or more after a first primary breast cancer (n = 705) and controls with unilateral breast cancer (n = 1,398) were ascertained from an underlying population-based cohort of 52,536 women diagnosed with a first invasive breast cancer before age 55 years. Interviews and medical record reviews were used to collect risk factor and treatment histories. All women were tested for BRCA1/BRCA2 mutations. Relative (rate ratios) and absolute (5- and 10-year cumulative) risks of developing contralateral breast cancer following a first invasive breast cancer were computed.

Results: Compared with noncarriers, BRCA1 and BRCA2 mutation carriers had 4.5-fold (95% CI, 2.8- to 7.1-fold) and 3.4-fold (95% CI, 2.0- to 5.8-fold) increased risks of contralateral breast cancer, respectively. The relative risk of contralateral breast cancer for BRCA1 mutation carriers increased as age of first diagnosis decreased. Age-specific cumulative risks are provided for clinical guidance.

Conclusion: The risks of subsequent contralateral breast cancer are substantial for women who carry a BRCA1/BRCA2 mutation. These findings have important clinical relevance regarding the assessment of BRCA1/BRCA2 status in patients with breast cancer and the counseling and clinical management of patients found to carry a mutation.

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.24.2495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881721PMC
May 2010
53 Reads

Publication Analysis

Top Keywords

breast cancer
56
contralateral breast
32
breast
14
cancer
14
mutation carriers
12
brca1 brca2
12
associated carrying
8
tested brca1/brca2
8
cumulative risks
8
invasive breast
8
subsequent contralateral
8
risks contralateral
8
cancer associated
8
cancer diagnosed
8
brca1/brca2 mutations
8
contralateral
8
mutation
6
risks
5
cancer invasive
4
cancer computedresults
4

Altmetric Statistics

Similar Publications